SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001104659-23-107370 from ESSA Pharma Inc. (EPIX) (CIK 0001633932)

ESSA Pharma Inc. (EPIX) (CIK 0001633932)
Date: Oct. 6, 2023 · CIK: 0001633932 · Accession: 0001104659-23-107370

AI Filing Summary & Sentiment

File numbers found in text: 333-274584

Date
October 10, 2023
Author
Hong
Form
CORRESP
Company
ESSA Pharma Inc. (EPIX) (CIK 0001633932)

Letter

October 6, 2023

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, DC 20549-3561

Attn: Daniel Crawford

Alan Campbell

Re: ESSA Pharma Inc.

Registration Statement on Form S-3 (File No. 333-274584)

Ladies and Gentlemen:

On behalf of ESSA Pharma Inc. (the “Company”), we respectfully request that the U.S. Securities and Exchange Commission take appropriate action to accelerate the effective date of the Registration Statement on Form S-3 (File No. 333-274584) (the “Registration Statement”) pursuant to Rule 461 under the Securities Act of 1933, as amended, so that the Registration Statement will be declared effective at 4:00 p.m. Eastern Time on October 10, 2023 or as soon thereafter as is practicable.

We also request that the undersigned of Skadden, Arps, Slate, Meagher & Flom LLP, the Company’s counsel, be notified of such effectiveness by a telephone call at (212) 735-2227 and that such effectiveness also be confirmed in writing.

Very truly yours,
/s/ Michael J.
Hong

Show Raw Text
CORRESP
1
filename1.htm

October
6, 2023

VIA EDGAR

United States
Securities and Exchange Commission

Division of Corporation
Finance

Office of Life
Sciences

100 F Street,
N.E.

Washington, DC
20549-3561

Attn:       Daniel
Crawford

 Alan
Campbell

 Re: ESSA Pharma Inc.

    Registration Statement on Form S-3 (File No. 333-274584)

Ladies and Gentlemen:

On
behalf of ESSA Pharma Inc. (the “Company”), we respectfully request that the U.S. Securities
and Exchange Commission take appropriate action to accelerate the effective date of the Registration Statement on Form S-3 (File No.
333-274584) (the “Registration Statement”) pursuant to Rule 461 under the Securities Act of 1933, as amended, so that the
Registration Statement will be declared effective at 4:00 p.m. Eastern Time on October 10, 2023 or as soon thereafter as is practicable.

We
also request that the undersigned of Skadden, Arps, Slate, Meagher & Flom LLP, the Company’s counsel, be notified of such effectiveness
by a telephone call at (212) 735-2227 and that such effectiveness also be confirmed in writing.

    Very truly yours,

    /s/ Michael J.
    Hong

    Michael J. Hong

cc:        David Parkinson